AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS · Delayed Price · Currency is USD
0.0169
+0.0029 (20.71%)
At close: Jan 23, 2026
AXIM Biotechnologies Market Cap
AXIM Biotechnologies has a market cap or net worth of $6.01 million as of January 23, 2026. Its market cap has increased by 891.92% in one year.
Market Cap
6.01M
Enterprise Value
12.79M
Revenue
92.90K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since October 9, 2013, AXIM Biotechnologies's market cap has increased from 1.98M to 6.01M, an increase of 203.54%. That is a compound annual growth rate of 9.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 4.98M | 30.84% |
| Dec 31, 2025 | 3.81M | 528.02% |
| Dec 31, 2024 | 605.90K | -86.58% |
| Dec 29, 2023 | 4.52M | -12.57% |
| Dec 30, 2022 | 5.16M | -91.35% |
| Dec 31, 2021 | 59.71M | 10.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clearside Biomedical | 4.76M |
| Mosaic ImmunoEngineering | 4.69M |
| Vaccinex | 3.16M |
| Enzon Pharmaceuticals | 3.12M |
| Burzynski Research Institute | 2.51M |
| Enzolytics | 2.42M |
| ProtoKinetix | 2.37M |
| Agentix | 2.00M |